R&D News | pharmaphorum

News

Hope for Alzheimer’s treatment after promising study results

Biogen and Eisai said their latest clinical study confirmed the amyloid hypothesis and might lead to the first drug successfully treating Alzheimer’s disease, instantly bumping their share

News

Study indicates potential breakthrough HIV drug

French biotech Abivax might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment.

News

Review finds medical benefits of cannabis-based drugs

The use of medical cannabis in the UK has moved a step closer, after the home secretary asked for advice following a review that concluded that there is evidence of therapeutic benefit.

R&D

AstraZeneca cancer drugs approved in Japan

AstraZeneca secured a fast approval of lung and breast cancer drugs with usually sluggish Japanese regulators, just months after scoring similar approvals in

News

A sad young woman is sitting in her kitchen with a headache

Lilly joins CGRP race to cure migraine

Eli Lilly are gearing up to announce details from the latest Emgality analysis, which can potentially push the biotech to the leading pack of the migraine cure race, among Allergan, Amgen a

Partner Content